Lessons in Global Health Leadership with the CEO of GlaxoSmithKline (GSK)


On September 23, 2016, the Aspen Institute’s Global Health and Development Program and USAID’s Center for Accelerating Innovation and Impact (CII) held a discussion with Sir Andrew Witty, CEO of GSK, about opportunities for public-private collaboration to advance global health in the developing world. In this discussion, Sir Andrew Witty shared leadership insights from his career making the business case for prioritizing global health in GSK’s global portfolio. He also discussed how the private and public sectors can collaborate to accelerate progress in global health, highlighting AMP Health as an example.

Watch the discussion here.